Psychedelic Research Comes to Texas for Treatment of Anxiety, Depression, and PTSD

After a mind-bending 2020 and 2021, mental health has come to the forefront of public discussion.

 
Psychedelic Mushrooms
Credit: @kirillvasilevcom via Twenty20

According to the Texas Health and Human Services Commission, more than 3 million Texas adults live with a mental illness. Close to 754,000 adults have had serious thoughts of suicide in the last year, and 61% of adults in Texas who needed mental health treatment last year did not receive any treatment. As the pandemic ranges on, the demand for access to mental health services and alternative treatment methods is rising.


Alternative Medicine


One of those revolutionary alternative treatment methods is sweeping through research institutions across the United States. Psychedelic research on psilocybin, ayahuasca, LSD, MDMA, and ketamine are being explored as effective treatment options for mental health disorders such as anxiety, depression, and post-traumatic stress disorder (PTSD).


It is important to note that these substances are not new and have been researched for quite some time; however, given the stigma brought on by the “War on Drugs” and misinformation campaigns, these powerful substances have been disregarded as suitable alternatives for pharmaceuticals and have largely lacked academic research, similar to cannabis.

Given the recent advancements and developments in psychedelic research and the demand for alternative treatment methods, large institutions have begun developing research programs such as the John Hopkins Center for Psychedelic and Consciousness Research. The use of psychedelics as an effective tool for treating mental health disorders is on its way to being a common practice.


Psychedelic Research in Texas


Now, a well-known Texas institution is investing in researching the power of psychedelics for mental health treatment. Researchers at the Dell Medical School at the University of Texas at Austin have launched the Center for Psychedelic Research and Therapy. The Center for Psychedelic Research and Therapy will be the first of its kind in Texas.


According to a press release, the center will conduct clinical research to better understand the potential for drugs such as psilocybin, MDMA, ibogaine, and ayahuasca to treat severe depression, anxiety, and PTSD when used as part of treatment with a trained provider.


“The research will bring further scientific rigor and expertise to study psychedelic therapy,” center co-lead Charles B. Nemeroff, professor and chair of Dell Med’s Department of Psychiatry and Behavioral Sciences and holder of the Mathew P. Nemeroff Endowed Chair, said in the release. “Recent studies have demonstrated considerable promise for these drugs when incorporated with clinical support, and this work has the potential to transform how we treat conditions like depression and PTSD and to identify synergies between these and other well-established therapies to achieve long-term benefits for those seeking treatment.”


The initial focus of the center will be on military veterans living with PTSD, adults experiencing prolonged grief disorder or depression, and those who have experienced childhood trauma.


Texas is home to the nation’s second-largest veteran population at 1.6 million, and Central Texas is home to 250,000 veterans. The center will be a valuable resource for veterans facing PTSD and other mental health disorders resulting from their military service.

 

Looking for more information?


Click here for the original press release from Dell Medical School at the University of Texas at Austin.


National Suicide Hotline

Veteran Crisis Line: 1-800-273-8255 (press 1) or Veteran Crisis Line Confidential Online Chat


Psychedelics info on the business of psychedelics: Microdose


*Microdose is a media company providing a guide to the business of psychedelics with the goal of distributing and creating the most compelling content, financial analysis, engaging events, and groundbreaking education to drive the psychedelics industry into the forefront of modern medicine